nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Feeling cold—Hydrochlorothiazide—nephrolithiasis	0.0473	0.0743	CcSEcCtD
Zuclopenthixol—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0295	CcSEcCtD
Zuclopenthixol—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0183	0.0287	CcSEcCtD
Zuclopenthixol—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0277	CcSEcCtD
Zuclopenthixol—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0172	0.027	CcSEcCtD
Zuclopenthixol—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0172	0.0508	CbGpPWpGaD
Zuclopenthixol—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0262	CcSEcCtD
Zuclopenthixol—DRD5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0148	0.0436	CbGpPWpGaD
Zuclopenthixol—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0212	CcSEcCtD
Zuclopenthixol—DRD5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0124	0.0367	CbGpPWpGaD
Zuclopenthixol—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0192	CcSEcCtD
Zuclopenthixol—HTR6—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0114	0.0337	CbGpPWpGaD
Zuclopenthixol—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0176	CcSEcCtD
Zuclopenthixol—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.011	0.0172	CcSEcCtD
Zuclopenthixol—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0171	CcSEcCtD
Zuclopenthixol—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0169	CcSEcCtD
Zuclopenthixol—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0166	CcSEcCtD
Zuclopenthixol—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0165	CcSEcCtD
Zuclopenthixol—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0164	CcSEcCtD
Zuclopenthixol—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0163	CcSEcCtD
Zuclopenthixol—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0162	CcSEcCtD
Zuclopenthixol—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0102	0.016	CcSEcCtD
Zuclopenthixol—DRD1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00981	0.029	CbGpPWpGaD
Zuclopenthixol—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00974	0.0153	CcSEcCtD
Zuclopenthixol—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00967	0.0152	CcSEcCtD
Zuclopenthixol—HTR6—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00958	0.0283	CbGpPWpGaD
Zuclopenthixol—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00923	0.0145	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00907	0.0142	CcSEcCtD
Zuclopenthixol—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0139	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00866	0.0136	CcSEcCtD
Zuclopenthixol—DRD1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00825	0.0244	CbGpPWpGaD
Zuclopenthixol—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00794	0.0125	CcSEcCtD
Zuclopenthixol—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00794	0.0125	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00782	0.0123	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00775	0.0122	CcSEcCtD
Zuclopenthixol—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00772	0.0121	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00766	0.012	CcSEcCtD
Zuclopenthixol—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00741	0.0219	CbGpPWpGaD
Zuclopenthixol—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00738	0.0116	CcSEcCtD
Zuclopenthixol—HTR2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00729	0.0215	CbGpPWpGaD
Zuclopenthixol—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00727	0.0215	CbGpPWpGaD
Zuclopenthixol—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00726	0.0114	CcSEcCtD
Zuclopenthixol—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00714	0.0211	CbGpPWpGaD
Zuclopenthixol—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00706	0.0111	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00669	0.0105	CcSEcCtD
Zuclopenthixol—ADRA2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00663	0.0196	CbGpPWpGaD
Zuclopenthixol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00655	0.0103	CcSEcCtD
Zuclopenthixol—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00994	CcSEcCtD
Zuclopenthixol—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00623	0.0184	CbGpPWpGaD
Zuclopenthixol—HTR2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00613	0.0181	CbGpPWpGaD
Zuclopenthixol—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00611	0.0181	CbGpPWpGaD
Zuclopenthixol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00607	0.00952	CcSEcCtD
Zuclopenthixol—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.006	0.0177	CbGpPWpGaD
Zuclopenthixol—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00928	CcSEcCtD
Zuclopenthixol—Chlorprothixene—CHRM3—nephrolithiasis	0.00586	0.241	CrCbGaD
Zuclopenthixol—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00914	CcSEcCtD
Zuclopenthixol—Tension—Hydrochlorothiazide—nephrolithiasis	0.0058	0.00911	CcSEcCtD
Zuclopenthixol—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00901	CcSEcCtD
Zuclopenthixol—ADRA2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00557	0.0165	CbGpPWpGaD
Zuclopenthixol—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00557	0.00875	CcSEcCtD
Zuclopenthixol—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00869	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00861	CcSEcCtD
Zuclopenthixol—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00853	CcSEcCtD
Zuclopenthixol—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00837	CcSEcCtD
Zuclopenthixol—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00834	CcSEcCtD
Zuclopenthixol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0053	0.00832	CcSEcCtD
Zuclopenthixol—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00529	0.00831	CcSEcCtD
Zuclopenthixol—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00523	0.0082	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0052	0.00816	CcSEcCtD
Zuclopenthixol—Loxapine—CHRM3—nephrolithiasis	0.00511	0.21	CrCbGaD
Zuclopenthixol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00504	0.0079	CcSEcCtD
Zuclopenthixol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00502	0.00787	CcSEcCtD
Zuclopenthixol—Quetiapine—CHRM3—nephrolithiasis	0.00499	0.205	CrCbGaD
Zuclopenthixol—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00497	0.00781	CcSEcCtD
Zuclopenthixol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00773	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00757	CcSEcCtD
Zuclopenthixol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00745	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00742	CcSEcCtD
Zuclopenthixol—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00739	CcSEcCtD
Zuclopenthixol—DRD5—G alpha (s) signalling events—PTH—nephrolithiasis	0.00468	0.0138	CbGpPWpGaD
Zuclopenthixol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00732	CcSEcCtD
Zuclopenthixol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00722	CcSEcCtD
Zuclopenthixol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00708	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0044	0.0069	CcSEcCtD
Zuclopenthixol—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00438	0.0129	CbGpPWpGaD
Zuclopenthixol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00685	CcSEcCtD
Zuclopenthixol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00433	0.0068	CcSEcCtD
Zuclopenthixol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00675	CcSEcCtD
Zuclopenthixol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00673	CcSEcCtD
Zuclopenthixol—Clozapine—CHRM3—nephrolithiasis	0.00429	0.177	CrCbGaD
Zuclopenthixol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00667	CcSEcCtD
Zuclopenthixol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00658	CcSEcCtD
Zuclopenthixol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00653	CcSEcCtD
Zuclopenthixol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00648	CcSEcCtD
Zuclopenthixol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00648	CcSEcCtD
Zuclopenthixol—Chlorpromazine—CHRM3—nephrolithiasis	0.00404	0.166	CrCbGaD
Zuclopenthixol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00624	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00619	CcSEcCtD
Zuclopenthixol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00599	CcSEcCtD
Zuclopenthixol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00599	CcSEcCtD
Zuclopenthixol—HTR6—G alpha (s) signalling events—PTH—nephrolithiasis	0.00362	0.0107	CbGpPWpGaD
Zuclopenthixol—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00356	0.00558	CcSEcCtD
Zuclopenthixol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00543	CcSEcCtD
Zuclopenthixol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00536	CcSEcCtD
Zuclopenthixol—ADRA2A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00337	0.00995	CbGpPWpGaD
Zuclopenthixol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00518	CcSEcCtD
Zuclopenthixol—HTR2A—GPCRs, Other—CHRM3—nephrolithiasis	0.00324	0.00957	CbGpPWpGaD
Zuclopenthixol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00501	CcSEcCtD
Zuclopenthixol—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00315	0.00932	CbGpPWpGaD
Zuclopenthixol—DRD1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00311	0.00919	CbGpPWpGaD
Zuclopenthixol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00307	0.00482	CcSEcCtD
Zuclopenthixol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00478	CcSEcCtD
Zuclopenthixol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00477	CcSEcCtD
Zuclopenthixol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00474	CcSEcCtD
Zuclopenthixol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00287	0.0045	CcSEcCtD
Zuclopenthixol—DRD5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00285	0.00842	CbGpPWpGaD
Zuclopenthixol—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00282	0.00834	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00265	0.00782	CbGpPWpGaD
Zuclopenthixol—HTR2A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00252	0.00744	CbGpPWpGaD
Zuclopenthixol—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00251	0.00742	CbGpPWpGaD
Zuclopenthixol—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00246	0.00728	CbGpPWpGaD
Zuclopenthixol—DRD5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00244	0.00721	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00225	0.00665	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00225	0.00664	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0022	0.00651	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0022	0.0065	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—RGS14—nephrolithiasis	0.00215	0.00636	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00214	0.00631	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.002	0.00592	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—RGS14—nephrolithiasis	0.00195	0.00577	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00189	0.00559	CbGpPWpGaD
Zuclopenthixol—HTR6—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00188	0.00557	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR ligand binding—CHRM3—nephrolithiasis	0.00186	0.00549	CbGpPWpGaD
Zuclopenthixol—HTR2A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00182	0.00538	CbGpPWpGaD
Zuclopenthixol—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00182	0.00536	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00179	0.00529	CbGpPWpGaD
Zuclopenthixol—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00178	0.00526	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR ligand binding—PTH—nephrolithiasis	0.0017	0.00502	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—RGS14—nephrolithiasis	0.00166	0.00491	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00163	0.00481	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00162	0.0048	CbGpPWpGaD
Zuclopenthixol—DRD1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00162	0.00479	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00159	0.00471	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—RGS14—nephrolithiasis	0.00151	0.00446	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—DGKH—nephrolithiasis	0.00145	0.00429	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—CHRM3—nephrolithiasis	0.00144	0.00424	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00143	0.00422	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00143	0.00422	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00141	0.00416	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0014	0.00415	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00138	0.00407	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ADCY10—nephrolithiasis	0.00136	0.00401	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—DGKH—nephrolithiasis	0.00132	0.0039	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR ligand binding—PTH—nephrolithiasis	0.00131	0.00388	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.0013	0.00384	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00128	0.00378	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00124	0.00365	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00122	0.00362	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00121	0.00356	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0012	0.00355	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00118	0.00349	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—RGS14—nephrolithiasis	0.00115	0.00341	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—PTH—nephrolithiasis	0.00113	0.00334	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—DGKH—nephrolithiasis	0.00112	0.00331	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0011	0.00324	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00108	0.00319	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00106	0.00314	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00106	0.00313	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00105	0.0031	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ADCY10—nephrolithiasis	0.00105	0.0031	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00104	0.00307	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.00103	0.00305	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.00103	0.00305	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—DGKH—nephrolithiasis	0.00102	0.00301	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.00098	0.0029	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000966	0.00285	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000966	0.00285	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000964	0.00285	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.000962	0.00284	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—PTH—nephrolithiasis	0.000961	0.00284	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—CHRM3—nephrolithiasis	0.000954	0.00282	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000944	0.00279	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000933	0.00276	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000918	0.00271	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000916	0.00271	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.000902	0.00266	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000899	0.00265	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RGS14—nephrolithiasis	0.000891	0.00263	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000877	0.00259	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.000877	0.00259	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—PTH—nephrolithiasis	0.000873	0.00258	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000853	0.00252	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000839	0.00248	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000838	0.00247	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000835	0.00247	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000822	0.00243	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000811	0.0024	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—DGKH—nephrolithiasis	0.00078	0.0023	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00078	0.0023	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RGS14—nephrolithiasis	0.000767	0.00227	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000764	0.00226	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—PTH—nephrolithiasis	0.000742	0.00219	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CHRM3—nephrolithiasis	0.000736	0.00218	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000729	0.00215	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000717	0.00212	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000716	0.00211	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000702	0.00208	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000698	0.00206	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000681	0.00201	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—PTH—nephrolithiasis	0.000674	0.00199	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00067	0.00198	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.000669	0.00198	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000662	0.00196	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000656	0.00194	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000653	0.00193	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000651	0.00192	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.00065	0.00192	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.000638	0.00189	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000638	0.00188	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000634	0.00187	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00062	0.00183	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00061	0.0018	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—DGKH—nephrolithiasis	0.000602	0.00178	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000602	0.00178	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000593	0.00175	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—PTH—nephrolithiasis	0.00058	0.00171	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000579	0.00171	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.00057	0.00168	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000568	0.00168	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CHRM3—nephrolithiasis	0.000564	0.00167	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000558	0.00165	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.000552	0.00163	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000527	0.00156	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000519	0.00153	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000518	0.00153	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—DGKH—nephrolithiasis	0.000518	0.00153	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000518	0.00153	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000517	0.00153	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PTH—nephrolithiasis	0.000515	0.00152	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000508	0.0015	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000482	0.00142	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000479	0.00141	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000474	0.0014	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.000473	0.0014	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000472	0.00139	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000471	0.00139	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00047	0.00139	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.00047	0.00139	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—APRT—nephrolithiasis	0.00047	0.00139	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000464	0.00137	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000461	0.00136	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.000438	0.00129	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CHRM3—nephrolithiasis	0.000435	0.00129	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000432	0.00128	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.000431	0.00127	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.00043	0.00127	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000428	0.00127	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000422	0.00125	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000404	0.00119	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PTH—nephrolithiasis	0.000398	0.00118	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000392	0.00116	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000391	0.00116	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000391	0.00116	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000385	0.00114	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.000385	0.00114	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000384	0.00113	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000384	0.00113	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000377	0.00111	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000377	0.00111	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000374	0.00111	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.00036	0.00106	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00035	0.00103	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.00035	0.00103	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PTH—nephrolithiasis	0.000343	0.00101	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000335	0.000989	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000306	0.000904	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000306	0.000904	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000303	0.000894	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000283	0.000835	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000278	0.000822	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000278	0.00082	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000272	0.000805	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SPP1—nephrolithiasis	0.000259	0.000765	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000259	0.000764	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.000254	0.000752	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.000254	0.00075	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000253	0.000748	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000249	0.000736	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000231	0.000684	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000218	0.000644	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SPP1—nephrolithiasis	0.0002	0.00059	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000197	0.000583	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000172	0.000508	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.00013	0.000384	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	0.000128	0.000377	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SPP1—nephrolithiasis	0.000127	0.000377	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000125	0.00037	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000116	0.000343	CbGpPWpGaD
